S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AKTX Akari Therapeutics PLC

0.97

-0.085 (-8.06%)

Feb 21 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Wednesday 19 February 2025 (5 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 14 February 2025 (1 week ago) • Edgar (US Regulatory)

Akari Therapeutics Joins Webull Corporate Connect Service Platform
Monday 3 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

Pinkslip Finance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions